99% Savings - Buy Urjas Massage Oil Just @1 Rs
Glimitab M 1 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Diabetes. Secondary and off-label uses of Glimitab M 1 Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Glimitab M 1 Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Common side effects of Glimitab M 1 Tablet include Headache, Nausea or vomiting, Dizziness. Some other side effects of Glimitab M 1 Tablet have been listed ahead. Normally, these side effects of Glimitab M 1 Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
In addition, Glimitab M 1 Tablet's effect is Unknown during pregnancy and Safe for lactating mothers. Warnings related to Glimitab M 1 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Glimitab M 1 Tablet is contraindicated in people with pre-existing medical conditions like Heart Disease, Kidney Disease, Liver Disease as it can result in adverse effects. Other conditions have been mentioned below in the Glimitab M 1 Tablet contraindications section.
Drug reaction of Glimitab M 1 Tablet with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Glimitab M 1 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Glimitab M 1 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glimitab M 1 Tablet safe for pregnant women?
Side effects of Glimitab M during pregnancy are not known because scientific research on this topic hasn't been done.
Is the use of Glimitab M 1 Tablet safe during breastfeeding?
Breastfeeding women can safely use Glimitab M.
What is the effect of Glimitab M 1 Tablet on the Kidneys?
Glimitab M may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Glimitab M 1 Tablet on the Liver?
There may be an adverse effect on the liver after taking Glimitab M. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Glimitab M 1 Tablet on the Heart?
Glimitab M is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Glimitab M 1 Tablet unless your doctor advises you to do so -
Is this Glimitab M 1 Tablet habit forming or addictive?
No, there is no any evidence that Glimitab M 1 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Glimitab M 1 Tablet. So it is best to avoid driving.
Is it safe?
Yes, Glimitab M 1 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Glimitab M 1 Tablet for mental disorders.
Interaction between Food and Glimitab M 1 Tablet
There is no information on the effects of taking Glimitab M 1 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Glimitab M 1 Tablet
Due to lack of research, there is no information about the side effects of taking Glimitab M 1 Tablet with alcohol.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826